Atin Biopolymer Company (privately held company) is a knowledge enterprise producing innovative biopolymer and hydro-polymer products as well as supplements and raw materials. The company was registered in 2005 in Tehran (CRN: 256098). Atin activities revolve around producing and supplying various medical equipment and their related materials, various wound coverings and
dermatological patches as well as hydro-polymer and biopolymer products.
The term “biotechnology” was coined by Károly Ereky in 1919 in the sense of using biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use.
Atin Biopolymer Company (privately held company) was founded in 2005 in Tehran (CRN: 256098). The initial mission was to innovate in the production of industrial products. In the first phase, the goal was to produce liquid paraffin based on the most up to date technology and with the participation of international partners, which despite the provision of land and launching the plant in Eshtehard Industrial Town, the project did not come to fruition due to problems on the supply of raw materials and technical know-how, and finally, in November 2012, the company’s subject of activity changed to produce and supply a variety of medical equipment and its related materials, various types of wound coverings and dermatological patches, hydro-polymer and biopolymer products, and nanotechnology.
With the conviction of the heart, Atin is determined to implement its master plan (including 3 sub-projects) as an effort to improve human life and uphold human values, while paying attention to the need for economic efficiency, progression based on the necessary principles and new methods and leading an efficient production unit and believes in the commercialization and transformation of Iranian technical knowledge and inventions into a quality and effective product for the benefit of mankind, a goal that will be achieved soon by the collective endeavor of Atin’s expansive team.
Our Competitive Advantages
The key benefits of the Atin’s master plan are briefly listed as follows:
- The products of this project are unique at both domestic and international levels
- Benefiting from higher qualitative advantages than other similar products available
- The ability to supply the raw materials domestically
- The equipment and the machinery used in the production lines are designed and manufactured by inventors and machine-building groups, composed of all domestic experts within the country
- Reducing the dependence of the medical equipment market on foreign products and the issues related to supplying them
- Preventing the withdrawal of significant amounts of currency from the country to import similar items with lower quality
- Significantly reducing the prices of the products for end consumers
- Considerable direct and indirect employment
- Potential broad market for exporting products, selling technology or creating partnerships with foreign companies
- Not causing environmental pollutions in the production and other processes
- Pollution-free production processes
- Proof of effectiveness and obtaining objective and practical results from the products based on clinical trials and use of patients in different treatment periods
- A significant reduction in treatment costs imposed on people, government and health insurance companies in the country
- The ability to quickly develop and launch new production lines and possibly factories if the predicted demand of the market is realized
- Relatively low investment volume and desirability of economic and financial indicators
- Decent profitability even on the basis of minimal initial capacity
There are several reasons for the above-mentioned advantages:
- Local production technology and technical know-how: All Atin’s products are produced based on innovative and unique technologies at international level and are more efficient than similar domestic and foreign products.
- Significant export markets available: Currently, no company in Iran is a producer of chitin, chitosan and its derivatives on an industrial scale, and Iran is an importer of these products. Atin’s main competitors are international chitosan manufacturers, including American, European and especially South East Asian companies. Generally, active producers in the Asia-Pacific region have also targeted export markets in North America and Europe. Japan and after that China, are the largest producers and consumers of chitosan in the region. Atin’s Marketing Management Team, in conjunction with R&D teams, has set up reliable international relationships with European pharmaceutical companies and cosmetics manufacturers to ensure that as soon as the industrial production starts, exports of surplus raw materials and supplements and Atin’s other competitive products are globalized, and the position of this business in the value chain of the industry is also consolidated.
- tested high performance products: Based on clinical trials conducted with all of Atin’s products, the effectiveness of drugs, supplements and ingredients has been proved with reliable evidence, as well as third-party recommendations and certifications (including organizations affiliated to the Ministry of Health and Medical Education, and other government agencies and privately owned laboratories). It should be noted that these products have no similarity to other available products in terms of formulas and constituent elements and are completely unique.
- Eco-Friendly products: Atin’s products are environmentally friendly and have no harmful environmental impact.
- Competitive prices: Products related to Atin’s projects are produced and supplied at very competitive and economical prices, although the initial investment costs of this plan, as well as its overhead operating costs in the area of marketing, are significant. Based on estimates from domestic and then Middle East and EU demand; the cost each unit of the product and its final delivery price are calculated in such a way that price-based competitiveness in the target markets will increase even more.
- The vast and growing use of Atin’s raw materials: New uses of chitosan are constantly being discovered, and the demand for it is also growing rapidly in global markets. According to a report by Global Industry Analysts, worldwide chitosan consumption will reach 40,500 tons per year by 2018, which is worth $ 35 billion.